FI854839A - VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID. - Google Patents
VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID. Download PDFInfo
- Publication number
- FI854839A FI854839A FI854839A FI854839A FI854839A FI 854839 A FI854839 A FI 854839A FI 854839 A FI854839 A FI 854839A FI 854839 A FI854839 A FI 854839A FI 854839 A FI854839 A FI 854839A
- Authority
- FI
- Finland
- Prior art keywords
- erhaollen
- daeri
- anvaendbar
- fraon
- vaccin
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 101100148710 Clarkia breweri SAMT gene Proteins 0.000 title 1
- 239000012502 diagnostic product Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The invention describes a polypeptide that is smaller than a naturally occurring gonococcal pilus protein but is capable of immunologically simulating a preserved antigen determinant position within a varying area in the carboxy terminal half of a gonococcal pilus protein, as well as vaccines, innocula, immunization methods and diagnostic tests using such a polypeptide, as well as antibodies produced by means of the polypeptides.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59743484A | 1984-04-06 | 1984-04-06 | |
US59743484 | 1984-04-06 | ||
US8500565 | 1985-04-04 | ||
PCT/US1985/000565 WO1985004654A1 (en) | 1984-04-06 | 1985-04-04 | A peptide vaccine or diagnostic, and a polypeptide useful therefor |
Publications (4)
Publication Number | Publication Date |
---|---|
FI854839A true FI854839A (en) | 1985-12-05 |
FI854839A0 FI854839A0 (en) | 1985-12-05 |
FI81452B FI81452B (en) | 1990-06-29 |
FI81452C FI81452C (en) | 1990-10-10 |
Family
ID=24391484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI854839A FI81452C (en) | 1984-04-06 | 1985-12-05 | Diagnostic system for determining the pilus protein of Neisseria gono rrhoeae bacterium |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0177583A4 (en) |
JP (1) | JPS61501777A (en) |
AU (1) | AU582358B2 (en) |
FI (1) | FI81452C (en) |
IL (1) | IL74829A (en) |
NO (1) | NO854903L (en) |
NZ (1) | NZ211715A (en) |
WO (1) | WO1985004654A1 (en) |
ZA (1) | ZA852629B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4736017A (en) * | 1984-04-30 | 1988-04-05 | The Board Of Trustees Of The Leland Stanford Junior University | Chemically defined vaccine against urinary infections |
US4584195A (en) * | 1984-06-21 | 1986-04-22 | The Board Of Trustees Of The Leland Stanford Junior University | Broad spectrum vaccine against gonorrhea |
IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
SE8601940D0 (en) * | 1986-04-25 | 1986-04-25 | Kabigen Ab | PREPARATION OF FUSED PROTEINS, ANTIBODIES AND PROCESSES THEREFOR |
WO1994008013A1 (en) * | 1992-10-07 | 1994-04-14 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Pilin variants and uses thereof |
AU3968599A (en) * | 1998-04-29 | 1999-11-16 | American Cyanamid Company | Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis |
US7189405B1 (en) | 1999-10-29 | 2007-03-13 | Rice Peter A | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4186182A (en) * | 1975-02-28 | 1980-01-29 | Research Corporation | Serological test for Neisseria gonorrhoeae antibodies |
US4461838A (en) * | 1975-04-25 | 1984-07-24 | Bactex, Inc. | Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae |
US4188371A (en) * | 1977-09-28 | 1980-02-12 | Corning Glass Works | Immunological detection of Neisseria bacteria via labelled antibodies |
US4351761A (en) * | 1978-05-15 | 1982-09-28 | Research Corporation | Purified antigen to test for Neisseria gonorrhoeae antibodies |
US4241045A (en) * | 1978-05-15 | 1980-12-23 | Research Corporation | Purified antigen to test for Neisseria gonorrheae antibodies |
US4330623A (en) * | 1980-02-19 | 1982-05-18 | Merck & Co., Inc. | Process for solubilization of gonococcal antigen |
US4386066A (en) * | 1981-08-20 | 1983-05-31 | Merck & Co., Inc. | Immunogenic complex from N. gonorrhoeae |
US4497900A (en) * | 1982-04-12 | 1985-02-05 | Abbott Laboratories | Immunoassay for Neisseria gonorrhoeae antigens |
-
1985
- 1985-04-04 WO PCT/US1985/000565 patent/WO1985004654A1/en not_active Application Discontinuation
- 1985-04-04 EP EP19850901876 patent/EP0177583A4/en not_active Withdrawn
- 1985-04-04 JP JP60501646A patent/JPS61501777A/en active Pending
- 1985-04-04 AU AU41590/85A patent/AU582358B2/en not_active Ceased
- 1985-04-05 IL IL74829A patent/IL74829A/en unknown
- 1985-04-09 ZA ZA852629A patent/ZA852629B/en unknown
- 1985-04-10 NZ NZ211715A patent/NZ211715A/en unknown
- 1985-12-05 NO NO854903A patent/NO854903L/en unknown
- 1985-12-05 FI FI854839A patent/FI81452C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI854839A0 (en) | 1985-12-05 |
IL74829A (en) | 1989-02-28 |
AU4159085A (en) | 1985-11-01 |
FI81452C (en) | 1990-10-10 |
FI81452B (en) | 1990-06-29 |
IL74829A0 (en) | 1985-07-31 |
EP0177583A4 (en) | 1988-06-08 |
AU582358B2 (en) | 1989-03-23 |
WO1985004654A1 (en) | 1985-10-24 |
ZA852629B (en) | 1985-11-27 |
NO854903L (en) | 1986-02-04 |
EP0177583A1 (en) | 1986-04-16 |
JPS61501777A (en) | 1986-08-21 |
NZ211715A (en) | 1989-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68924162D1 (en) | STRESS PROTEINS AND USES THEREFOR. | |
NO950328L (en) | Conjugates with weak immunogenic antigens and synthetic peptide carriers and vaccines containing them | |
WO1995029193A3 (en) | Melanoma antigens | |
HUP0202796A2 (en) | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens | |
NZ219113A (en) | Hiv peptide containing epitope of the env protein | |
NO934801D0 (en) | CTL4A receptor, fusion proteins containing it and its use | |
BR9306984A (en) | Peptide antigen analog of a native peptide antigen vaccine antibody process to vaccinate a host in need of this treatment kit diagnostic processes to prepare an antigen analog of a native peptide antigen to prepare a vaccine to analyze a sample for a peptide antigen native and to analyze a sample for an antibody | |
TR199801722T2 (en) | Peptide imm�nojenler. | |
YU152587A (en) | MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS | |
Jemmerson et al. | Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines. | |
HK1093314A1 (en) | Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens | |
AU7752487A (en) | Immunomodulating compositions and their use | |
DK461884D0 (en) | PROTECTIVE PEPTID ANTIGEN | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
ATE382699T1 (en) | METHOD FOR DESIGNING RECOMBITOPIC PEPTIDES | |
FI854839A (en) | VACCIN ELLER DIAGNOSTIC PRODUCT ERHAOLLEN FRAON PEPTID, SAMT DAERI ANVAENDBAR POLYPEPTID. | |
ES2052370T3 (en) | IMMUNOLOGICALLY ACTIVE PEPTIDES OR POLYPEPTIDES OF PARVOVIRUS B19. | |
ZA856655B (en) | Cross-reactive and protective epitopes of circumsporozoite proteins | |
DK76191A (en) | FILAMENTOEST HAEMAGGLUTININ FROM B.PERTUSSIS | |
WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
GB2314560A (en) | Synthetic peptides of m. gallisepticum, antibodies thereto, their preparations and use | |
ES8800052A1 (en) | Anaplasma marginale subunit antigen for vaccination and diagnosis. | |
DE69322960D1 (en) | CONCEPTIBLE VACCINE | |
IL91609A0 (en) | Allelic variants of plasmodium falciparum merozoite surface antigen | |
GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION |